Eurartesim (piperaquine tetraphosphate;artenimol)
- Region
- 🇪🇺 EU
- Active substance
- piperaquine tetraphosphate;artenimol
- Company
- Alfasigma S.p.A.
- Status
- Authorised
- Therapeutic area
- Malaria
- EU approval
- Thu 27 Oct 2011
- Application
- EMEA/H/C/001199
- ATC
- P01BF05
- Official record
- www.ema.europa.eu
Indication
Eurartesim is indicated for the treatment of uncomplicated Plasmodium falciparum malaria in adults, children and infants 6 months and over and weighing 5 kg or more. Consideration should be given to official guidance on the appropriate use of antimalarial agents.
Regulatory milestones
No milestones recorded in the last year.
Follow Eurartesim
Get VigiEye Daily: approvals, opinions, safety actions and PDUFA dates every morning.
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.